BIOMAT Database Logo BIOMAT Database Logo

Protein synthesis and tumorigenicity of the cytoplasmic hybrid between rat yolk sac tumor and mouse fibroblastic cell line. 1983

Y Tsukada, and M C Yoshida, and M Koura, and H Isaka, and T Sekiguchi, and H Hirai

Cytoplasmic hybrid (cybrid) cell lines were formed by fusing whole cells of rat yolk sac tumor cell line (EST-II) with cytoplasts of mouse fibroblastic cell line (B-82cap), a variant of mouse L cell line that is deficient in thymidine kinase (TK-) and resistant to chloramphenicol (capr). The cybrid cell line with the nucleus of EST-II and cytoplasma of B-82cap was successfully obtained using double selection with HAT and chloramphenicol-containing medium. The cybrid's ability to synthesize proteins such as albumin, alpha-fetoprotein, gamma-EST, and gamma-GTP was found to be approximately one-fourth that of the nuclear donor, EST-II, at a early time of growth in culture, but this was followed by a gradual increase during the period of observation. The nude mice undergoing subcutaneous transplantation of 1 X 10(6) cells of EST-II and cybrid were killed by the tumor growth, with the survival time being 56 +/- 11 and 105 +/- 25 days, respectively. The histologic findings of cybrid tumor closely resembled those of the nuclear donor, EST-II. These facts suggest that factors from both the nucleus and cytoplasma will be able to affect the gene expression of the cybrid cell line.

UI MeSH Term Description Entries
D008649 Mesonephroma A rare tumor of the female genital tract, most often the ovary, formerly considered to be derived from mesonephric rests. Two varieties are recognized: (1) clear cell carcinoma, so called because of its histologic resemblance to renal cell carcinoma, and now considered to be of muellerian duct derivation and (2) an embryonal tumor (called also ENDODERMAL SINUS TUMOR and yolk sac tumor), occurring chiefly in children. The latter variety may also arise in the testis. (Dorland, 27th ed) Mesonephromas
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009368 Neoplasm Transplantation Experimental transplantation of neoplasms in laboratory animals for research purposes. Transplantation, Neoplasm,Neoplasm Transplantations,Transplantations, Neoplasm
D002701 Chloramphenicol An antibiotic first isolated from cultures of Streptomyces venequelae in 1947 but now produced synthetically. It has a relatively simple structure and was the first broad-spectrum antibiotic to be discovered. It acts by interfering with bacterial protein synthesis and is mainly bacteriostatic. (From Martindale, The Extra Pharmacopoeia, 29th ed, p106) Cloranfenicol,Kloramfenikol,Levomycetin,Amphenicol,Amphenicols,Chlornitromycin,Chlorocid,Chloromycetin,Detreomycin,Ophthochlor,Syntomycin
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006825 Hybridomas Cells artificially created by fusion of activated lymphocytes with neoplastic cells. The resulting hybrid cells are cloned and produce pure MONOCLONAL ANTIBODIES or T-cell products, identical to those produced by the immunologically competent parent cell. Hybridoma
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014176 Protein Biosynthesis The biosynthesis of PEPTIDES and PROTEINS on RIBOSOMES, directed by MESSENGER RNA, via TRANSFER RNA that is charged with standard proteinogenic AMINO ACIDS. Genetic Translation,Peptide Biosynthesis, Ribosomal,Protein Translation,Translation, Genetic,Protein Biosynthesis, Ribosomal,Protein Synthesis, Ribosomal,Ribosomal Peptide Biosynthesis,mRNA Translation,Biosynthesis, Protein,Biosynthesis, Ribosomal Peptide,Biosynthesis, Ribosomal Protein,Genetic Translations,Ribosomal Protein Biosynthesis,Ribosomal Protein Synthesis,Synthesis, Ribosomal Protein,Translation, Protein,Translation, mRNA,mRNA Translations
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Y Tsukada, and M C Yoshida, and M Koura, and H Isaka, and T Sekiguchi, and H Hirai
Characterization of a rat yolk sac carcinoma cell line.
October 1982, Developmental biology,
Y Tsukada, and M C Yoshida, and M Koura, and H Isaka, and T Sekiguchi, and H Hirai
The synthesis of ribosomal protein and ribosomal RNA in a rat-mouse hybrid cell line.
March 1975, Experimental cell research,
Y Tsukada, and M C Yoshida, and M Koura, and H Isaka, and T Sekiguchi, and H Hirai
Fibroblastic potential of CD41+ cells in the mouse aorta-gonad-mesonephros region and yolk sac.
September 2012, Stem cells and development,
Y Tsukada, and M C Yoshida, and M Koura, and H Isaka, and T Sekiguchi, and H Hirai
Ultrastructural characterization of a mouse melanoma cell line, a mouse fibroblastic cell line, and hybrids between them.
April 1981, European journal of cell biology,
Y Tsukada, and M C Yoshida, and M Koura, and H Isaka, and T Sekiguchi, and H Hirai
Cytological distinction between clear cell carcinoma and yolk sac tumor of the ovary.
January 1996, European journal of gynaecological oncology,
Y Tsukada, and M C Yoshida, and M Koura, and H Isaka, and T Sekiguchi, and H Hirai
Growth of a human yolk sac tumor cell line with yolk sac-derived functions in selenium-supplemented chemically defined synthetic medium.
June 1992, In vitro cellular & developmental biology : journal of the Tissue Culture Association,
Y Tsukada, and M C Yoshida, and M Koura, and H Isaka, and T Sekiguchi, and H Hirai
p53 mutation decreased radiosensitivity in rat yolk sac tumor cell lines.
June 1999, International journal of radiation oncology, biology, physics,
Y Tsukada, and M C Yoshida, and M Koura, and H Isaka, and T Sekiguchi, and H Hirai
Tumorigenicity of nasopharyngeal carcinoma hybrid cell line.
September 1984, Journal of the National Cancer Institute,
Y Tsukada, and M C Yoshida, and M Koura, and H Isaka, and T Sekiguchi, and H Hirai
Protein synthesis by rat transplantable yolk sac tumor and its relation to the cytosol levels of translatable messenger RNA's.
December 1978, Cancer research,
Y Tsukada, and M C Yoshida, and M Koura, and H Isaka, and T Sekiguchi, and H Hirai
Synthesis of secretory proteins in developing mouse yolk sac.
March 1982, Developmental biology,
Copied contents to your clipboard!